Increased circulating phenylacetylglutamine concentration elevates the predictive value of cardiovascular event risk in heart failure patientsHaoran Wei, Dao Wen Wang, Lei Xiao et al.|Journal of Internal Medicine|2023Cited by 28
Gut microbiota-dependent phenylacetylglutamine in cardiovascular disease: current knowledge and new insightsYaonan Song, Dao Wen Wang, Haoran Wei et al.|Frontiers of Medicine|2024Cited by 27
Simultaneous quantitative LC-MS/MS analysis of 13 apolipoproteins and lipoprotein (a) in human plasmaYuxuan Zhang, Junfang Wu, Xuanru Ren et al.|The Analyst|2024Cited by 7
Asprosin attenuates diabetic cardiomyopathy through inhibiting autophagy mediated by AMPK/mTOR/ULK1 pathwayYuan Wang, Li Wang, Guohua Zeng et al.|American Journal of Physiology-Cell Physiology|2025Cited by 6
Role of Sodium Glucose Cotransporter 2 Inhibitor in HypertensionZhitong Zhou, Junfang Wu, Dao Wen Wang|International Journal of Drug Discovery and Pharmacology|2022Cited by 2